| 标题 |
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Katherine R Tuttle; Sibylle J. Hauske; María Eugênia Fernandes Canziani; Maria Luiza Caramori; David Z.I. Cherney; et al 出版日期:2023-12-15 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)